Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$568K Sell
1,614
-79
-5% -$28.2K 0.13% 153
2025
Q4
$554K Sell
1,693
-14
-0.8% -$4.44K 0.13% 146
2025
Q3
$482K Sell
1,707
-7
-0.4% -$2.03K 0.1% 155
2025
Q2
$479K Buy
1,714
+45
+3% +$12.7K 0.12% 160
2025
Q1
$519K Buy
1,669
+96
+6% +$28.3K 0.14% 132
2024
Q4
$410K Buy
+1,573
New +$467K 0.1% 158

Other funds holding AMGN

PKS Advisory Services's AMGN Position: Q1 2026 in Review

PKS Advisory Services reduced its Amgen (AMGN) stake by 4.7% in Q1 2026, selling an estimated $28.2K and leaving 1,614 shares worth $568K. The position accounts for 0.13% of the portfolio, ranked #153.

PKS Advisory Services first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • PKS Advisory Services held 1,614 shares of Amgen worth $568K as of Q1 2026.
  • PKS Advisory Services sold 79 Amgen shares in Q1 2026, an estimated $28.2K.
  • Amgen made up 0.13% of PKS Advisory Services's portfolio in Q1 2026, its #153 holding.
  • PKS Advisory Services first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on PKS Advisory Services's 13F filing for Q1 2026, filed 13 May 2026.